More Publications by © Chronicle Companies

n+p.PNG
Advertise with Derm.city
Chronicle Companies
Terms of Use Policy
Order "To Heal the Skin"

© Chronicle Companies 2018

Powered by Skin Chronicle International

  • Twitter - Black Circle
  • Facebook - Black Circle
  • YouTube - Black Circle
  • Home

  • Skin Chronicle

  • Primers for your Patient

  • Skin Spectrum Summit

  • Chronicle

  • Contact

  • More...

    Skin Cancer

    Beta blockers may make checkpoint inhibitors more reliable

    August 30, 2017

    |

    by John Evans, Associate Editor

    A preclinical study suggests that beta blocker medications, commonly prescribed for hypertension and cardiac arrhythmia among other conditions, may be the key to improving the reliability of checkpoint inhibitor medications in the treatment of cancers such as melanoma.

     

    In a paper published online ahead of print in Cancer Research (Aug. 17, 2017), investigators report that the immune regulator molecules known as beta-2 (β2) andrenergic receptors appear to control the functionality of some key immune cells. When exposed to environmental stressors, these molecules cause the cells to produce more of the stress hormone norepinephrine. This protects normal cells from some damaging effects, but can also impair the immune system’s ability to fight cancer, they note.

     

    Further studies showed that the β2 andrenergic receptor ADRB2 could be induced to reduce its signaling through the use of beta-blocker medications. This, in turn, might improve the efficacy of anti-PD-1 checkpoint blockade therapy.

     

    “Our bodies respond to certain types of stress — such as fear and anxiety, heat, cold, pain, depression and even attack by cancer cells — in the same way. We jump into ‘fight or flight’ mode, and the sympathetic nervous system dials up the release of norepinephrine,” senior author Elizabeth Repasky, PhD, said in a press release. Dr. Repasky is the Dr. William Huebsch Professor of Immunology at the Roswell Park Cancer Institute in Buffalo. 

     

    “For reasons that we don’t entirely understand yet, prolonged exposure to these stressors often makes our immune cells much less effective. But we demonstrate here that beta blockers, by reducing adrenergic signaling, allow anti-tumor immune cells to become much stronger, and give immunotherapies, and in particular checkpoint inhibitors, a much better chance to work.”

     

    Dr. Marc Ernstoff, the Katherine Anne Gioia Chair of Medicine at Roswell Park, said in the release that he expects to soon initiate a multicent​re clinical study based on these findings.

     

    “The possibility of improving responses to checkpoint inhibitors and perhaps expanding the numbers of patients who can benefit from them by pairing them with drugs that have been broadly available for years and are generally very well tolerated is quite compelling,” said Dr. Ernstoff. “We look forward to determining whether an approach that combines anti-PD-1 therapy with a beta blocker will be as effective as these intriguing preclinical studies suggest.”​

    Tags:

    Beta-blocker

    Checkpoint inhibitor

    Roswell Park Cancer Institute

    Elizabeth Repasky

    Marc Ernstoff

    melanoma

    cancer

    Please reload

    Featured Posts

    Epigenome a potential target for psoriasis Tx

    December 13, 2019

    New guidelines for rare and dangerous skin tumor

    December 11, 2019

    Reconsider gifting at-home beauty devices this holiday season

    December 9, 2019

    High-dose brachytherapy for BCC, SCC in older patients

    December 6, 2019

    Study: Makeup Products May Harbor Dangerous Bacteria

    December 4, 2019

    Newborn's immune system detects harmful skin bacteria

    December 2, 2019

    Topical rapamycin may slow skin aging

    November 29, 2019

    Statin medications may leave patients vulnerable to skin infections

    November 27, 2019

    Genes show how much sun exposure could lead to melanoma

    November 25, 2019

    Atopic eczema increases fracture risk

    November 22, 2019

    Please reload

    Archive

    December 2019 (6)

    November 2019 (11)

    October 2019 (11)

    September 2019 (13)

    August 2019 (13)

    July 2019 (12)

    June 2019 (11)

    May 2019 (17)

    April 2019 (15)

    March 2019 (13)

    February 2019 (11)

    January 2019 (13)

    December 2018 (12)

    November 2018 (13)

    October 2018 (14)

    September 2018 (9)

    August 2018 (9)

    July 2018 (9)

    June 2018 (13)

    May 2018 (11)

    April 2018 (13)

    March 2018 (13)

    February 2018 (14)

    January 2018 (12)

    December 2017 (6)

    November 2017 (11)

    October 2017 (5)

    September 2017 (4)

    August 2017 (6)

    July 2017 (10)

    June 2017 (12)

    May 2017 (17)

    April 2017 (12)

    March 2017 (19)

    February 2017 (11)

    January 2017 (13)

    December 2016 (11)

    November 2016 (13)

    October 2016 (16)

    September 2016 (16)

    August 2016 (14)

    July 2016 (16)

    June 2016 (16)

    May 2016 (22)

    April 2016 (17)

    March 2016 (15)

    February 2016 (12)

    January 2016 (11)

    December 2015 (13)

    November 2015 (19)

    October 2015 (13)

    September 2015 (15)

    July 2015 (3)

    June 2015 (22)

    March 2015 (3)

    Please reload

    Follow Us
    • Grey Facebook Icon
    • Grey YouTube Icon
    • Grey Instagram Icon
    • Grey Twitter Icon